BioAge Labs BIOA
NASDAQ BIOA
$5.52 -0.04 (-0.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Debt Ratio (2023 - 2026)

Updated

BioAge Labs' (BIOA) Debt Ratio was 0.00 for Q1 2026, down 85.8% from 0.02 a year earlier and down 67.5% from the prior quarter.

Analysis

BioAge Labs (BIOA) Debt Ratio (2023 - 2026) Analysis & Trends

For FY2025, Debt Ratio at BioAge Labs was 0.01, down 62.2% from FY2024.

  • By year, Debt Ratio came in at 0.02 in FY2024 (-95.7%) and 0.55 in FY2023.
  • The Q1 2026 figure ranks as the lowest quarterly Debt Ratio in data going back to Q4 2023.
  • Year over year, Debt Ratio has now declined in each of the last three quarters, with an average decline of 74.4% over the last four quarters.
  • Per Business Quant data, the three quarters before Q1 2026 came in at 0.01 (Q4 2025), 0.01 (Q3 2025) and 0.02 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 BioAge Labs 245.72 Mn -1.55 Bn -14.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.03
Dec 31, 2023 0.55
API Access

BioAge Labs Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BIOA&period=max&api_key=YOUR_API_KEY